Is Cannabidiol During Neurodevelopment a Promising Therapy for Autism? The question of whether cannabidiol (CBD), a compound derived from the cannabis plant, could serve as an effective therapy for autism spectrum disorder (ASD) during neurodevelopmental stages is gaining significant attention in the scientific community. As detailed in a comprehensive review Read more…
The therapeutic potential of cannabidiol (CBD), a non-psychoactive component of cannabis, has been increasingly recognized in various biomedical fields. CBD has been shown to possess a wide range of properties beneficial for managing and potentially treating different health conditions. A key review documented in the study, “Cannabidiol as an Emergent Read more…
Recent research delves into the pharmacological landscape of GPR18, a G-protein-coupled receptor, and its activation by cannabinoid compounds. This pivotal study, titled “Activation of GPR18 by cannabinoid compounds: a tale of biased agonism”, unveils the complexities of GPR18’s interaction with cannabinoids, revealing a nuanced mode of action termed biased agonism. Read more…
Psoriasis, a chronic skin condition with no definitive cure, affects millions globally, creating a necessity for innovative treatments. A groundbreaking study published by Journal of Clinical Medicine offers new insights into the potential benefits of cannabidiol (CBD) for psoriasis sufferers. Titled “Cannabidiol Decreases Metalloproteinase Activity and Normalizes Angiogenesis Factor Expression Read more…
Recent research has brought to light the potential of cannabidiol (CBD), a non-psychoactive component of cannabis, for the treatment of anxiety disorders. The study, titled “Cannabidiol as a Potential Treatment for Anxiety Disorders” and published in the journal Neurotherapeutics, provides a comprehensive look into the existing preclinical and clinical evidence Read more…
Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in adults, characterized by rapid growth and resistance to conventional therapies. The prognosis for GBM patients is poor, with a median survival time of just over 14 months post-diagnosis. As such, the quest for novel and Read more…
In a groundbreaking study published in the Frontiers in Pharmacology journal, researchers discovered that oral administration of cannabidiol (CBD) may prevent the development of allodyniaβa condition where pain is caused by stimuli that normally do not provoke painβand other neurological impairments in a mouse model of mild traumatic brain injury Read more…
Unlocking New Potentials in Pancreatic Cancer Treatment: Cannabidiol Meets Oxygen-Ozone Therapy Current advancements in cancer research are continuously exploring unconventional methods to enhance cancer treatment efficacy. A novel study, published in the National Library of Medicine, sheds light on the potential synergistic effects of combining cannabidiol (CBD) and oxygen-ozone therapy Read more…
The multifaceted compound, Cannabidiol (CBD), has been the subject of extensive scientific research due to its potential therapeutic benefits and non-psychoactive nature. A recent analysis published in the NCBI (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489340/), examines the pharmacological properties, safety, efficacy, and regulatory status of CBD. In this summarized review, we provide a synthesis of Read more…
Study Overview An emerging treatment approach for glioblastoma multiforme (GBM), one of the most aggressive and lethal forms of brain cancer, has been examined in a pivotal study. This approach involves the local delivery of cannabinoid-loaded microparticles, which has demonstrated significant efficacy in inhibiting tumor growth within a murine xenograft Read more…